Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells.

ABSTRACT:

SUBMITTER: Kuang P 

PROVIDER: S-EPMC9630128 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature